Genetic testing in prolactinomas: a cohort study
Amina Boukerrouni(Inserm), Pauline Romanet(Inserm), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), E. Sonnet(Centre Hospitalier Régional Universitaire de Brest), Jean-Christophe Maïza(Hôpital Rangueil), Anne Barlier(Inserm), Rachel Reynaud(Hôpital de la Timone), Hanitra Randrianaivo(Centre Hospitalier Universitaire de La Réunion), Amandine Ferrière(Centre Hospitalier Universitaire de Bordeaux), V. Kerlan(Centre Hospitalier Régional Universitaire de Brest), Nicolas Chevalier(Inserm), Brigitte Delemer(Centre Hospitalier Universitaire de Reims), Philippe Thuillier(Centre Hospitalier Régional Universitaire de Brest), I. Raingeard(Centre Hospitalier Universitaire de Montpellier), Thierry Brue(Inserm), Nicolas Sahakian(Inserm), Thomas Cuny(Hôpital de la Conception), Henry Dufour(Inserm), Laurence Salle(Inserm), Patricia Niccoli(Institut Paoli-Calmettes), Solange Grunenwald(Hôpital Larrey), E. Marquant(Inserm), Sarah Fodil-Cherif(Centre Hospitalier Universitaire de Montpellier), Thibaut Anjou(Inserm), Antoine Tabarin(Université de Bordeaux), Frédéric Castinetti(Inserm)
Cited by 9
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
Human Health and Ocean Pollution
|Annals of Global Health|2020|751